Abstract
COVID-19 is treated with antisense oligonucleotides (ASOs) targeting SARS-CoV-2 viral RNAs or human ACE2 RNA.
Original language | English |
---|---|
IPC | C12N 15/ 86 A I |
Priority date | 06/08/2020 |
Priority number | US202163147225P |
Publication status | Published - 10 Feb 2022 |